APAC Melanoma Diagnostics and Therapeutics Market, Market Segmented, by Cancer Type (Superficial, Nodular, Lentigo Maligna, Acral Lentiginous and Amelanotic Melanoma), by Cancer Stage (Stage 0, Stage I, Stage II, Stage III, and Stage IV), by Diagnosis (Dermatoscopy, Sentinel Lymph Node Biopsy, X-Rays, Blood Tests, CT Scan, and Ultrasound), and by Treatment (Treatment For Early Stage Melanoma, and Treatment For Advanced Stage Melanoma) - Growth, Trends and Forecast, 2019-2028
- Published Date: 2022-12-26
- Report ID: 138306
- Pages: 200
-
Format:
Report Overview
The APAC Melanoma Diagnostics and Therapeutics Market, market size stood at around USD $0.5 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period
Melanomais a form ofskin cancer that develops in cells called melanocytes that make melanin, the pigment that gives skin its natural color
Market Drivers
Increase in melanoma cases and approval and uptake of premium-priced products. Effective immunotherapies, label extension of current therapies into the new settings, government initiatives, and technological advancement are driving the market
Lack of awareness in some developing regions and high cost associated with the therapy as well as economic crisis and regulatory issues are hindering the market growth
1. APAC Melanoma Diagnostics and Therapeutics Market Overview
A. Market Size
2. APAC Melanoma Diagnostics and Therapeutics Growth Drivers and Restraints
A. Increase in melanoma cases and approval and uptake of premium-priced products
B. Effective immunotherapies, label extension of current therapies into the new settings, government initiatives, and technological advancements
C. Lack of awareness in some developing regions and high cost associated with the therapy
D. Economic crisis and regulatory issues
3. APAC Melanoma Diagnostics and Therapeutics Market Segmentation
A. By Cancer Type
I. Superficial
II. Nodular
III. Lentigo Maligna
IV. Acral Lentiginous
V. Amelanotic Melanoma
B. By Cancer Stage
I. Stage 0
II. Stage I
III. Stage II
IV. Stage III
V. Stage IV)
C. By Diagnosis
I. Dermatoscopy
II. Sentinel Lymph Node Biopsy
III. X-Rays
IV. Blood Tests
V. CT Scan
VI. Ultrasound
D. By Treatment
I. Treatment for Early-Stage Melanoma
II. Treatment for Advanced Stage Melanoma
4. Melanoma Diagnostics and Therapeutics Market Share
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles..
A. Bristol-Myers Squibb, Company overview, Product & Services, Strategies & Financials
B. Eli Lilly, Company overview, Product & Services, Strategies & Financials
C. GlaxoSmithKline, Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Potential Growth Opportunities
A. Market Opportunities
B. Future Trends
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
